← Back to catalogue

TeleRPM Gen2 Blood Glucose Monitoring System

FDA 510(k)EUDAMED

Class II (US FDA 510(k))

510(k) K243060Ref TMB-2092-G

by Guangdong Transtek Medical Electronics Co., Ltd

Identity

Trade Name
TeleRPM EUDAMED
Device Name
Blood Pressure Monitor EUDAMED
Model / Reference
TMB-2092-G EUDAMED

Identifiers

Primary DI / UDI-DI
06932825305838 EUDAMED
Basic UDI-DI
69328253MDR10PR EUDAMED
Direct Marketing DI
06932825305838 EUDAMED
510(k) Number
K243060 FDA 510(k)
FDA Product Code
NBW FDA 510(k)
EMDN Code
Z1203020501 NON–INVASIVE OSCILLOMETRIC BLOOD PRESSURE GAUGES EUDAMED

Classification

Device Class
Class IIa EUDAMED
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 862.1345 FDA 510(k)
Regulation Number
862.1345 FDA 510(k)
Market of Registration
Germany EUDAMED
Advisory Committee
Clinical Chemistry FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

Clinical & Handling

Sterile

No

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

Yes

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

The TeleRPM Gen2 Blood Glucose Monitoring System is a Blood Glucose Monitoring Device (NBW) designed to quantitatively measure glucose concentration in fresh capillary whole blood using an amperometric detection method. It falls under the Clinical Chemistry category and is classified as a Class II device under FDA regulations (862.1345).

This system is intended for single-use in clinical settings, such as hospitals or laboratories, where precise glucose measurements are required. Supplied sterile and non-reusable, it adheres to FDA 510(k) clearance (K243060) and EU MDR compliance. No MRI safety information is specified, and storage conditions are not detailed in the available data.

Frequently asked questions

What types of clinical settings is the TeleRPM Gen2 Blood Glucose Monitoring System designed for, and how is it intended to be used there?

The TeleRPM Gen2 is specifically designed for single-use in clinical settings like hospitals or laboratories where accurate glucose measurements are critical. It measures glucose concentration in fresh capillary whole blood using an amperometric detection method, ensuring precise results for patient care in controlled environments.

Is the TeleRPM Gen2 Blood Glucose Monitoring System reusable, or is it meant for one-time use?

The TeleRPM Gen2 is explicitly intended for single-use only, as stated in its design and supply specifications. This ensures sterility and safety for clinical environments where precision and contamination control are essential.

What kind of regulatory approvals does the TeleRPM Gen2 Blood Glucose Monitoring System hold, and how does that affect its use?

The device holds FDA 510(k) clearance (K243060) and EU MDR compliance, confirming it meets regulatory standards for safety and performance. This approval allows it to be legally marketed and used in the U.S. and EU for its intended clinical purpose—quantitative glucose measurement in capillary whole blood.

How is the TeleRPM Gen2 Blood Glucose Monitoring System supplied, and what does that mean for handling and storage?

The system is supplied sterile, which means it is pre-sterilized to prevent contamination before use. While storage conditions aren’t detailed in the data, the single-use nature implies it should be stored in a clean, dry environment away from direct light or extreme temperatures to maintain its integrity until use.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: K243060 - TeleRPM Gen2 Blood Glucose Monitoring S..., PDF K243060 - accessdata.fda.gov, TeleRPM Gen2 Blood Glucose Monitoring System - BEUDAMED, TeleRPM Gen2 Blood Glucose Monitoring System — FDA K243060

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

MDR

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

FDA Applicant
Guangdong Transtek Medical Electronics Co., Ltd.

Sources (2)

  • FDA 510(k) K243060 24 fields · synced Oct 6, 2026
  • EUDAMED 105738d5-0698-45ba-b204-19b2060efa17 61 fields · synced Aug 2, 2026